Potassium hydroxide -concentrated smears, prepared from sedimented remains of clinical specimens, were used to distinguish between mold infection and exogenous contamination in fungal culture -positive specimens. This method was applied in the study of 3,857 clinical specimens from 230 bone marrow transplant recipients who were followed up prospectively for infectious complications. Concentrated smears of only 86 (from 21 infected patients) of 149 fungal culturepositive specimens were positive for hyphae; 82 of the strains were Aspergillus species. Concentrated smears of the remaining 63 fungal culture -positive specimens were negative; the strains identified by culture were considered as exogenous contaminants (87% of which were Penicillium species). A stage-specific manifestation of mold infection was observed: 67% of mold infections occurred during acute graft-vs.-host disease (GVHD) a median of 47 days after transplantation, whereas 9% of mold infections occurred as rapidly fatal invasive disease before engraftment. Overall, of the 21 patients with mold infection, 17 (81%) had invasive mold disease, and four (19%) had mold colonization of airways secondary to chronic GVHD after day 100. The significant risk factors for mold infection were total-body irradiation and grade 2 -4 acute GVHD. Because of our high mortality rate (82%), the consideration of antimold prophylaxis for such patients may be warranted.
Since the last decade, molds are gaining prominence as opin the environment and are often disregarded in cultures of portunistic pathogens. In immunocompetent hosts, molds rarely nonsterile specimens such as sputum, urine, stool, and superficause serious illnesses, except for indwelling device -associcial swabs. In the absence of clinical evidence, the presence ated infections, posttraumatic mycetoma, aspergilloma in paof molds in these specimens usually indicates contamination tients with preexisting chronic lung diseases, and self-limiting by fungal spores during collection and processing or colonizadiffuse pneumonitis after massive inhalation of spores. Howtion of fungal spores on damaged airways, mucosal lesions, ever, molds cause life-threatening diseases in immunosupand superficial skin [5] . pressed hosts, especially patients with AIDS, neutropenic paSeveral laboratory criteria (e.g., the presence of characteristic tients, and solid organ and bone marrow transplant (BMT) fungal elements in smears and multiple cultures of the same recipients [1, 2] . Most invasive diseases due to molds are species) have been proposed to exclude exogenous contaminacaused by Aspergillus species. In one study [3] , infections with tion. However, the sensitivity of detection by smear examinathis mold occurred in 8.7% of allogeneic BMT patients. In tion is low, and consecutive specimens for culture are usually another study [4] , the mortality rate associated with aspergillus not available. The sensitivity or specificity of alternative diaginfection in patients with pulmonary involvement and persistent nostic approaches, such as the detection of fungal antigens or neutropenia was 95%.
DNA amplification, has also been found to be low [6] . The successful management of mold infections is hampered
The definitive diagnosis of invasive disease requires the isoby difficulties in establishing diagnoses. Molds are ubiquitous lation of mold in culture and histological demonstration of its presence [7] . Yet, in one study [8] , the predictive value of positive cultures of respiratory tract specimens from neutro-smear as a rapid and sensitive diagnostic tool to differentiate spectively prepared and examined; only concentrated smears of BAL fluid specimens were prepared directly and examined. genuine mold infection from contamination. A prospective study of 3,857 clinical specimens from 230 BMT patients was Before microscopic examination and culture of the specimens were performed, respiratory secretions were pretreated conducted; direct and concentrated smears of fungal culturepositive specimens were prepared and examined. The clinical with Sputasol (Oxoid, Basingstoke Hampshire, United Kingdom), and tissue biopsy specimens were homogenized in micorrelation of positive concentrated smears, the temporal sequence of the onset of infection, and the risk factors for mold crofuge tubes containing PBS. For microscopic examination, tissue biopsy specimens were further digested in 20% (w/v) infections were analyzed. The results of this study are presented herein.
KOH solution at 37ЊC for 15 minutes. To prepare a direct KOH smear by wet mounting, 20 mL of the specimen was mixed with an equal volume of 20% KOH solution, placed on a glass slide, and mounted under a coverslip. The slide was screened at Patients and Methods low-power magnification (1100) under dark-field illumination; septate hyaline hyphae with uniform diameters (4 mm) and Patients and antimicrobial prophylaxis. Two hundred thirty patients who underwent bone marrow transplantation at dichotomous branching at 45Њ were highly suggestive of Aspergillus. the Queen Mary Hospital in Hong Kong during a 5-year period (1991 -1995) were included in this study. Before transplantaEach specimen was inoculated onto two plates with Sabouraud dextrose agar supplemented with chloramphenicol (50 tion, all patients were admitted to protective isolation rooms with high efficiency particulate air filtration [9] . Patients who mg/L); the plates were incubated at 25ЊC and 37ЊC. The remains of each specimen were kept at 4ЊC for 2 weeks before were receiving BMTs from mismatched siblings or matched unrelated donors (MUDs) were admitted to rooms that were disposal. Mold isolates were identified by standard morphological criteria [13] . The day on which positive growth was visually also equipped with laminar airflow [10]; these patients underwent total-gut decontamination with tobramycin (80 mg q.i.d.), observed and the site and number of cfu on the agar were recorded. vancomycin (500 mg q.i.d.), and nystatin (10 mL q.i.d.).
From day 0 until stable engraftment, all patients were treated The corresponding refrigerated clinical sample of the fungal culture -positive specimen was retrieved for the preparation of with chlorhexidine mouthwash, amphotericin B lozenges, ciprofloxacin (500 mg b.i.d.), and acyclovir (200 mg t.i.d.)
concentrated smears. The maximal amount of each specimen was digested in an equal volume of 20% KOH solution and [11, 12] . When patients developed neutropenia and fever, they were treated empirically with iv imipenem/cilastin (10 mg/kg centrifuged at 5,000 rpm for 10 minutes at room temperature. Swab specimens positive for fungi were vortexed in Eppendorf q6h). If fever persisted for 48 hours and the workup for sepsis was negative, iv vancomycin (10 mg/kg q6h) was added to tubes containing PBS to recover fungal elements and concentrated by centrifugation. All but Ç100 mL of the supernatant the treatment. On the fifth day of neutropenia and fever, iv amphotericin B therapy (0.5 mg/[kgrd]) was initiated. If mold fluid was decanted; an aliquot of the fluid was mounted on a glass slide and examined as described above. infection was documented or suspected on clinical and microbiological grounds, the dosage of amphotericin B was increased Definitions. Invasive mold disease was defined either by culture and histological examination of a biopsy or autopsy to 1.5 mg/(kgrd).
All patients undergoing allogeneic or MUD transplantation tissue specimen revealing mold or by culture and examination of a direct smear showing mold, a compatible clinical and received the following as prophylaxis for acute graft-vs.-host disease (GVHD): 15 mg of iv methotrexate/m 2 on day 1; 10 radiological picture, and no response to antibacterial therapy. A positive culture without documented evidence of invasive mg of iv methotrexate/m 2 on days 3, 6, and 11; and 5 mg of oral cyclosporine/kg b.i.d. from day 1 to day 50 or 1.5 mg of disease could be due to colonization or exogenous contamination. Acute myeloid leukemia and acute lymphoblastic leukeiv cyclosporine/kg q12h from day 1 to day 50 when the patient could not tolerate oral medication. mia in the first complete remission, chronic myeloid leukemia in chronic phase, lymphoma in the first complete remission, Microbiological methods. One week before and up to 1.5 years after transplantation or until death, each patient's medical myeloma in complete remission, and severe aplastic anemia in patients younger than 25 years of age who were not receiving progress was recorded, and clinical specimens from each patient were collected. Routine surveillance cultures of stool, immunosuppressive therapy were considered as early underlying diseases. Any other underlying diseases were considered nasal swabs, and throat swabs were performed weekly to detect fungi and multidrug-resistant bacteria. All respiratory secreas late diseases. Data analyses. A comparison of microbiological charactertions, including sputa, endotracheal aspirates, and bronchoalveolar lavage (BAL) fluids, were cultured for bacteria, mycoistics between concentrated smear -positive, fungal culturepositive specimens and concentrated smear -negative, fungal bacteria, Legionella, and fungi. Direct smears of only tissue and respiratory specimens undergoing fungal culture were preculture -positive specimens was performed by the x 2 test. Univariate logistic analysis was performed to identify risk factors pared for microscopic examination for mold. Concentrated smears of all fungal culture -positive specimens were retrofor infections by molds. On the basis of the results of the / 9c33$$jy01 06-13-97 19:27:29 cidal UC: CID univariate logistic analysis, variables with P values of õ.05 or median period from inoculation to detection of visible growth for the concentrated smear -positive specimens was 3 days those known to be biologically important were included in a multivariate logistic analysis. The backward elimination less than that for the concentrated smear -negative specimens. Multiple colonies were growing on the agar for all concentrated method was used to select variables. The importance of each factor to the model was assessed by the likelihood ratio; a twosmear -positive specimens; these colonies were all found on the primary streak line. In addition, 12 specimens from patients tailed x 2 test was used to determine this ratio. with invasive diseases who were receiving antifungal therapy were culture-negative but concentrated smear -positive, a findResults ing with implications for therapeutic monitoring (these implications are reviewed under Discussion). Fungal cultures of 149 of 3,857 clinical specimens (of which 1,072 were derived from febrile neutropenic patients) were
During the study period, 21 (9%) of 230 BMT patients had culture-documented infection by molds (table 2). These infecpositive; concentrated smears of 86 of these 149 fungal culture -positive specimens were positive for mold (table 1) . Not tions were diagnosed a median of 67 days after transplantation. Invasive diseases occurred in 17 patients (81%), while four unexpectedly, there was an absolute correlation between the results of the examinations of concentrated smears and those (19%) had colonization. The respiratory tracts of these four patients were colonized with Aspergillus species (one with of the examinations of the direct smears. Several statistically significant differences (P õ .05) were noted between concenthree Aspergillus species) after day 100, and all four did not have evidence of mold infection earlier in their clinical courses trated smear -negative specimens and concentrated smearpositive specimens. Concentrated smear -positive specimens when they were neutropenic. Most of the infections were caused by Aspergillus flavus were taken mainly from sinopulmonary sites or biopsied tissues.
(38%), Aspergillus fumigatus (19%), and other Aspergillus species (28%). The lung and paranasal sinuses (86%) were the Most isolates (95%) from concentrated smear -positive specimens were Aspergillus species, while 87% and 3% of the predominant sites of infection [14] . Extrasinopulmonary infections involved the brain, skin and soft tissue, gastrointestinal fungal isolates from concentrated smear -negative specimens were Penicillium and Aspergillus species, respectively. The tract, and ear. Most infections occurred after engraftment (me- The possible risk factors for infection by molds are presented Brain 3 (14) in the entire field of the smear can be completely evaluated for these large fungal elements at a magnification of 1100 within 2 minutes. However, it would not be practical and cost-effective dian time of onset of infection, 47 days); 14 patients (67%) were receiving immunosuppressive treatment for acute GVHD.
to incorporate this method into routine mycology procedures because there would be a tremendous increase in the work Only two patients with severe neutropenia (9%) developed infection before engraftment; both had severe diffuse pulmoload. Therefore, immediate preparation and examination of concentrated smears of specimens from patients suspected of nary disease with extrapulmonary dissemination. Thirteen patients (62%) developed neutropenia and fever early after transhaving mold infection or of selected specimens (e.g., BAL fluid) would definitely help in establishing a diagnosis earlier. plantation, but none of these patients had any other clinical or radiological evidence of invasive disease. Concomitant cytoFurthermore, the concentrated smear may also be useful in monitoring the progress of treatment, since cultures become megalovirus (CMV) disease occurred in 11 patients; these patients received ganciclovir therapy. Two of these 11 patients less sensitive after the initiation of antifungal therapy. After ascertaining the value of the concentrated smear, we developed severe neutropenia secondary to ganciclovir therapy just before the onset of invasive mold disease and required explored the clinical aspects and possible implications for mold infection. A stage-specific pattern of mold infection therapeutic support with growth factors; however, none of these patients became more neutropenic after the diagnosis of mold was found. Most mold infections occurred after engraftment during the period of acute GVHD; only two of the 17 episodes disease.
Of the 17 patients with invasive mold disease, 14 were of invasive disease with extrasinopulmonary dissemination occurred in the neutropenic period during the first 30 days, and treated with iv amphotericin B (1 -1.5 mg/[kgrd]), and three were treated with iv liposomal amphotericin B (3 mg/[kgrd] 
